Illinois State University researcher Jamie Whelan presented findings that portable mass spectrometers could screen drug evidence on-site, yield detection rates comparable to laboratory analysis, and reduce lab backlogs and per-sample costs under some scenarios; she also flagged legal questions about probable cause and user bias.